Diana Brixner
- Economics and Econometrics top 2%
- General Health Professions top 10%
- Statistics and Probability top 2%
- Oncology
- Surgery
- Co-authors
- Wim GoettschMarc L. BergerJohn B. WatkinsAmr MakadySebastian SchneeweißDavid MadiganShirley WangRosanna Tarricone
- Topics
- Health Systems, Economic Evaluations, Quality of Life (16 papers)Pharmaceutical Economics and Policy (8 papers)Pharmaceutical Practices and Patient Outcomes (5 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Diana Brixner
33 papers receiving 941 citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Economics and Econometrics 461
- General Health Professions 194
- Statistics and Probability 143
- Oncology 96
- Surgery 79
Countries citing papers authored by Diana Brixner
This map shows the geographic impact of Diana Brixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Brixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Brixner more than expected).
Fields of papers citing papers by Diana Brixner
This network shows the impact of papers produced by Diana Brixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Brixner. The network helps show where Diana Brixner may publish in the future.
Co-authorship network of co-authors of Diana Brixner
This figure shows the co-authorship network connecting the top 25 collaborators of Diana Brixner. A scholar is included among the top collaborators of Diana Brixner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Brixner. Diana Brixner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 65 | |
| 10 | Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Makingbreakdown → | 327 |
| 11 | 1 | |
| 12 | 2 | |
| 13 | Consideration of international generic distribution policies on patient outcomes in the United States and Germany. | 3 |
| 14 | 7 | |
| 15 | 1 | |
| 16 | Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets. | 12 |
| 17 | 39 | |
| 18 | 92 | |
| 19 | 15 | |
| 20 | 1 |
About Diana Brixner
Diana Brixner is a scholar working on Geriatrics and Gerontology, Family Practice and Economics and Econometrics, having authored 37 papers that have together received 977 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Economics and Policy (8 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). The work is most often cited by research in Statistics and Probability (143 citations), Economics and Econometrics (461 citations) and Family Practice (22 citations). Diana Brixner has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Wim Goettsch, Marc L. Berger, John B. Watkins, Amr Makady, Sebastian Schneeweiß, David Madigan, Shirley Wang, Rosanna Tarricone, C. Daniel Mullins and Harold C. Sox. Their work appears in journals such as American Journal of Hypertension, Value in Health and Health Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.